|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jan 06 | Option Exercise | 0.00 | 3,750 | 0 | 13,453 | Jan 07 09:17 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 25 | Option Exercise | 0.00 | 3,750 | 0 | 11,441 | Nov 26 04:30 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jan 06 | Option Exercise | 0.00 | 3,750 | 0 | 9,438 | Jan 08 08:48 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 25 | Option Exercise | 0.00 | 3,750 | 0 | 7,389 | Nov 27 09:48 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Oct 08 | Option Exercise | 9.29 | 23,500 | 218,315 | 27,139 | Oct 09 06:42 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Oct 08 | Sale | 76.34 | 23,500 | 1,794,082 | 3,639 | Oct 09 06:42 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 17 | Option Exercise | 5.60 | 400 | 2,240 | 4,039 | Jun 18 09:51 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 17 | Sale | 70.20 | 400 | 28,081 | 3,639 | Jun 18 09:51 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 17 | Option Exercise | 5.60 | 24,000 | 134,400 | 27,639 | Jun 17 09:55 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 17 | Sale | 70.20 | 24,000 | 1,684,870 | 3,639 | Jun 17 09:55 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 08 | Option Exercise | 5.60 | 600 | 3,360 | 4,239 | Jun 10 09:24 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jun 08 | Sale | 70.05 | 600 | 42,027 | 3,639 | Jun 10 09:24 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Jan 09 | Option Exercise | 31.32 | 1,590 | 49,806 | 3,639 | Jan 10 07:46 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Dec 18 | Option Exercise | 0.00 | 3,750 | 0 | 3,750 | Dec 20 09:40 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 21 | Option Exercise | 0.61 | 21,065 | 12,850 | 21,065 | Nov 22 09:36 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 20 | Option Exercise | 0.61 | 3,935 | 2,400 | 3,935 | Nov 22 09:36 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 20 | Sale | 53.03 | 3,935 | 208,665 | 0 | Nov 22 09:36 PM |
| BHVN | Gentile Kimberly | SVP, Clinical Operations | Nov 21 | Sale | 53.04 | 21,065 | 1,117,205 | 0 | Nov 22 09:36 PM |
| BHVN | Gentile Kimberly | VP of Operations | Jun 15 | Option Exercise | 0.61 | 12,500 | 7,625 | 12,500 | Jun 19 04:43 PM |
| BHVN | Gentile Kimberly | VP of Operations | Jun 15 | Sale | 40.02 | 12,500 | 500,250 | 0 | Jun 19 04:43 PM |
| BHVN | Gentile Kimberly | VP of Operations | Mar 01 | Option Exercise | 0.61 | 5,000 | 3,050 | 5,000 | Mar 05 04:31 PM |
| BHVN | Gentile Kimberly | VP of Operations | Mar 01 | Sale | 32.87 | 5,000 | 164,344 | 0 | Mar 05 04:31 PM |
| BHVN | Gentile Kimberly | VP of Operations | Feb 01 | Option Exercise | 0.61 | 5,000 | 3,050 | 5,000 | Feb 02 06:18 PM |
| BHVN | Gentile Kimberly | VP of Operations | Feb 01 | Sale | 32.78 | 5,000 | 163,900 | 0 | Feb 02 06:18 PM |
| BHVN | Gentile Kimberly | VP of Operations | Jan 02 | Option Exercise | 0.61 | 5,000 | 3,050 | 5,000 | Jan 03 05:28 PM |
| BHVN | Gentile Kimberly | VP of Operations | Jan 02 | Sale | 27.60 | 5,000 | 138,000 | 0 | Jan 03 05:28 PM |
| BHVN | Gentile Kimberly | VP of Operations | Dec 01 | Option Exercise | 0.61 | 5,000 | 3,050 | 5,000 | Dec 05 04:02 PM |
| BHVN | Gentile Kimberly | VP of Operations | Dec 01 | Sale | 21.99 | 5,000 | 109,962 | 0 | Dec 05 04:02 PM |
| BHVN | Gentile Kimberly | VP of Operations | Nov 01 | Option Exercise | 0.61 | 5,000 | 3,050 | 5,000 | Nov 02 05:57 PM |
| BHVN | Gentile Kimberly | VP of Operations | Nov 01 | Sale | 29.28 | 5,000 | 146,385 | 0 | Nov 02 05:57 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite